Page last updated: 2024-09-02

hydroxyitraconazole and aliskiren

hydroxyitraconazole has been researched along with aliskiren in 1 studies

Compound Research Comparison

Studies
(hydroxyitraconazole)
Trials
(hydroxyitraconazole)
Recent Studies (post-2010)
(hydroxyitraconazole)
Studies
(aliskiren)
Trials
(aliskiren)
Recent Studies (post-2010) (aliskiren)
872922978211611

Protein Interaction Comparison

ProteinTaxonomyhydroxyitraconazole (IC50)aliskiren (IC50)
ReninHomo sapiens (human)0.001
Renin-1 Mus musculus (house mouse)0.0045
Renin Rattus norvegicus (Norway rat)0.084
Cytochrome P450 3A4Homo sapiens (human)0.0004
Cytochrome P450 2C9 Homo sapiens (human)0.0023
ReninMacaca mulatta (Rhesus monkey)0.0012
Renin Oryctolagus cuniculus (rabbit)0.011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Backman, JT; Kurkinen, KJ; Neuvonen, PJ; Niemi, M; Tapaninen, T1

Trials

1 trial(s) available for hydroxyitraconazole and aliskiren

ArticleYear
Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren.
    Journal of clinical pharmacology, 2011, Volume: 51, Issue:3

    Topics: Adult; Amides; Antifungal Agents; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Fumarates; Half-Life; Humans; Itraconazole; Male; Metabolic Clearance Rate; Renin; Young Adult

2011